Four patents currently held, every record listed here
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Jan 2032. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jan 2032
Next term end
3
Patent families
When these terms end
Each bar runs from grant to computed term end. 2018 to 2043.20232028203320382043
A dotted end marks a recorded terminal disclaimer this site has not resolved: the term can only be shorter than the bar, never longer.
2 pending applications: term is not computable until grant.Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 2 of the currently held patents qualify as notable.
Notable
Ends Jan 2032 · High confidence
Also notable
Ends no later than May 2043 · Medium confidence
Method and Dyes for Detecting and Destroying Cancer Cells
US 10,030,036
Granted 2018 and renewed at every maintenance window due so far. Protection runs to 2032.
Near-Infrared Dyes And Conjugates For Targeting Tumors
US 12,752,023
Granted 2026. Too new for citation comparison; protection runs to 2043. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Fee deadlines
No maintenance fee falls due on this company's record before Nov 10, 2027.
Recent changes
- 1 of the patents on this record was granted since Aug 17, 2026
What they patent
The 2 largest of its 3 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Near-Infrared Dyes And Conjugates For Targeting Tumors (2020) | 2 in force | to Mar 2040 |
| Near-Infrared Dyes And Conjugates For Targeting Tumors (2025) | 1 in force | to May 2043 |
Patents held now
Soonest term end first.
Showing 1 to 4 of 4
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,030,036 | Method and Dyes for Detecting and Destroying Cancer Cells In force · High confidence | In force | High confidence | |
| US 12,109,276 | Near-Infrared Dyes And Conjugates For Targeting Tumors In force · High confidence | In force | High confidence | |
| US 12,599,682 | Near-Infrared Dyes And Conjugates For Targeting Tumors In force · High confidence | In force | High confidence | |
| US 12,752,023 | Near-Infrared Dyes And Conjugates For Targeting Tumors In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 4: 2 applications pending. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
1 terminal disclaimer is on file with no resolved reference. No cap is applied and none is guessed